12 results on '"Sakurai F"'
Search Results
2. Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus.
- Author
-
Ono R, Nishimae F, Wakida T, Sakurai F, and Mizuguchi H
- Subjects
- Humans, Mice, Animals, Adenoviridae genetics, Genetic Vectors genetics, Seroepidemiologic Studies, Transgenes, Antibodies, Viral, Luciferases genetics, Antibodies, Neutralizing genetics, Adenoviridae Infections genetics, Adenoviruses, Human genetics, Neoplasms therapy, Neoplasms genetics
- Abstract
Oncolytic adenoviruses (OAds), most of which are based on species C human adenovirus serotype 5 (Ad5) (OAd5), have recently received much attention as potential anticancer agents. High seroprevalence of anti-Ad5 neutralizing antibodies is a major hurdle for Ad5-based gene therapy. However, the impacts of anti-Ad5 neutralizing antibodies on OAd5-mediated transgene expression in the tumor and antitumor effects remain to be fully elucidated. In this study, we examined the impact of anti-Ad5 neutralizing antibodies on the OAd5-mediated antitumor effects and OAd5-mediated transgene expression. The luciferase expression of OAd-tAIB-Luc, which contains the cytomegalovirus promoter-driven luciferase gene, was inhibited in human cultured cells in the presence of human serum. Although the inhibitory effects of human serum possessing the low anti-Ad5 neutralizing antibody titers were overcome by long-term infection, the in vitro tumor cell lysis activities of OAd-tAIB-Luc were entirely attenuated by human serum containing the high titers of anti-Ad5 neutralizing antibodies. OAd-tAIB-Luc-mediated luciferase expression in the subcutaneous tumors 3 days after administration and tumor growth suppression levels following intratumoral administration were significantly lower in mice possessing the high titers of anti-Ad5 neutralizing antibodies, compared to those in control mice. These results suggested that pre-existing anti-Ad5 antibodies attenuated both transgene expression and potential antitumor effects of OAd5 following intratumoral administration., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
3. miR-27b antagonizes BMP signaling in early differentiation of human induced pluripotent stem cells.
- Author
-
Lim J, Sakai E, Sakurai F, and Mizuguchi H
- Subjects
- CRISPR-Cas Systems, Endoderm metabolism, Humans, Mesoderm metabolism, MicroRNAs genetics, RNA Interference, Bone Morphogenetic Proteins genetics, Bone Morphogenetic Proteins metabolism, Cell Differentiation genetics, Gene Expression Regulation, Developmental, Induced Pluripotent Stem Cells cytology, Induced Pluripotent Stem Cells metabolism, Signal Transduction
- Abstract
Human induced pluripotent stem (hiPS) cells are feasible materials for studying the biological mechanisms underlying human embryogenesis. In early embryogenesis, definitive endoderm and mesoderm are differentiated from their common precursor, mesendoderm. Bone morphogenetic protein (BMP) signaling is responsible for regulating mesendoderm and mesoderm formation. Micro RNAs (miRNAs), short non-coding RNAs, broadly regulate biological processes via post-transcriptional repression. The expression of miR-27b, which is enriched in somatic cells, has been reported to increase through definitive endoderm and hepatic differentiation, but little is known about how miR-27b acts during early differentiation. Here, we used miR-27b-inducible hiPS cells to investigate the roles of miR-27b in the undifferentiated and early-differentiated stages. In undifferentiated hiPS cells, miR-27b suppressed the expression of pluripotency markers [alkaline phosphatase (AP) and nanog homeobox (NANOG)] and cell proliferation. Once differentiation began, miR-27b expression repressed phosphorylated SMAD1/5, the mediators of the BMP signaling, throughout definitive endoderm differentiation. Consistent with the above findings, miR-27b overexpression downregulated BMP-induced mesendodermal marker genes [Brachyury, mix paired-like homeobox 1 (MIXL1) and eomesodermin (EOMES)], suggesting that miR-27b had an inhibitory effect on early differentiation. Collectively, our findings revealed a novel antagonistic role of miR-27b in the BMP signaling pathway in the early differentiation of hiPS cells., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
4. FGF signal is not required for hepatoblast differentiation of human iPS cells.
- Author
-
Toba Y, Kiso A, Nakamae S, Sakurai F, Takayama K, and Mizuguchi H
- Subjects
- Bone Morphogenetic Proteins metabolism, Cell Differentiation physiology, Endoderm cytology, Humans, Induced Pluripotent Stem Cells metabolism, Receptors, Fibroblast Growth Factor metabolism, Recombinant Proteins metabolism, Fibroblast Growth Factors metabolism, Hepatocytes metabolism, Induced Pluripotent Stem Cells physiology
- Abstract
Human induced pluripotent stem cell-derived hepatocyte-like cells are expected to be utilized in pharmaceutical research and regenerative medicine. In general, human induced pluripotent stem (iPS) cells are differentiated into hepatocyte-like cells through definitive endoderm cells and hepatoblast-like cells using various growth factors that are essential for liver development. Although recombinant bone morphogenetic proteins (BMPs) and fibroblast growth factors (FGFs) are widely used in the hepatoblast differentiation, hepatoblast differentiation process has not been fully modified. In this study, we examined the roles of BMPs and FGFs in the hepatoblast differentiation from human iPS cells. Surprisingly, the gene expression levels of hepatoblast markers were upregulated by the removal of FGFs. In addition, the percentages of hepatoblast markers-positive cells were increased by the removal of FGFs. Furthermore, the hepatocyte differentiation potency was also significantly increased by the removal of FGFs. To examine whether FGF signals are completely unnecessary for the hepatoblast differentiation, the expression levels of endogenous FGF ligands and receptors were examined. The definitive endoderm cells highly expressed the FGF ligand, FGF2, and the FGF receptor, FGFR1. To examine the role of endogenous FGF signals, an FGFR inhibitor was treated during the hepatoblast differentiation. The hepatoblast differentiation was promoted by using FGFR inhibitor, suggesting that endogenous FGF signals are also unnecessary for the hepatoblast differentiation. In conclusion, we found that FGF signals are not essential for hepatoblast differentiation. We believe that our finding will be useful for generating functional hepatocyte-like cells for medical applications.
- Published
- 2019
- Full Text
- View/download PDF
5. Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration.
- Author
-
Tomita K, Sakurai F, Iizuka S, Hemmi M, Wakabayashi K, Machitani M, Tachibana M, Katayama K, Kamada H, and Mizuguchi H
- Subjects
- Adenoviridae genetics, Animals, Female, Gene Dosage genetics, Genetic Vectors genetics, Mice, Mice, Inbred C57BL, Plasmids genetics, Transduction, Genetic methods, Adenoviridae immunology, Antibodies, Viral immunology, Capsid Proteins immunology, Liver metabolism
- Abstract
Pre-existing anti-adenovirus (Ad) neutralizing antibodies (AdNAbs) are a major barrier in clinical gene therapy using Ad vectors and oncolytic Ads; however, it has not been fully elucidated which Ad capsid protein-specific antibodies are involved in AdNAb-mediated inhibition of Ad infection in vivo. In this study, mice possessing antibodies specific for each Ad capsid protein were prepared by intramuscular electroporation of each Ad capsid protein-expressing plasmid. Ad vector-mediated hepatic transduction was efficiently inhibited by more than 100-fold in mice immunized with a fiber protein-expressing plasmid or a penton base-expressing plasmid. An Ad vector pre-coated with FX before administration mediated more than 100-fold lower transduction efficiencies in the liver of warfarinized mice immunized with a fiber protein-expressing plasmid or a penton base-expressing plasmid, compared with those in the liver of warfarinized non-immunized mice. These data suggest that anti-fiber protein and anti-penton base antibodies bind to an Ad vector even though FX has already bound to the hexon, and inhibit Ad vector-mediated transduction. This study provides important clues for the development of a novel Ad vector that can circumvent inhibition with AdNAbs.
- Published
- 2018
- Full Text
- View/download PDF
6. Direct conversion of human fibroblasts into hepatocyte-like cells by ATF5, PROX1, FOXA2, FOXA3, and HNF4A transduction.
- Author
-
Nakamori D, Akamine H, Takayama K, Sakurai F, and Mizuguchi H
- Subjects
- Activating Transcription Factors genetics, Activating Transcription Factors metabolism, Biomarkers, Cell Line, Gene Expression Profiling, Gene Expression Regulation, Developmental, Hepatocyte Nuclear Factor 3-beta genetics, Hepatocyte Nuclear Factor 3-beta metabolism, Hepatocyte Nuclear Factor 3-gamma genetics, Hepatocyte Nuclear Factor 3-gamma metabolism, Hepatocyte Nuclear Factor 4 genetics, Hepatocyte Nuclear Factor 4 metabolism, Humans, Transcription Factors metabolism, Transcriptome, Transduction, Genetic, Transgenes, Cell Transdifferentiation genetics, Cellular Reprogramming genetics, Fibroblasts cytology, Fibroblasts metabolism, Hepatocytes cytology, Hepatocytes metabolism, Transcription Factors genetics
- Abstract
Recently, it has been reported that human hepatocyte-like cells can be generated from fibroblasts by direct reprogramming technology. However, the conversion efficiency of human induced hepatocyte-like cells (hiHeps) is not high enough. In addition, comparative analysis with the existing models of hepatocytes, such as human iPS cell-derived hepatocyte-like cells and primary human hepatocytes, has not been sufficiently carried out. In this study, we screened hepatic transcription factors for efficient direct hepatic reprogramming and compared hepatic functions between hiHeps and other existing hepatocyte models. We found that human fibroblasts were efficiently converted into hiHeps by using a combination of ATF5, PROX1, FOXA2, FOXA3, and HNF4A (albumin+/alpha-1 antitrypsin+ cells = 27%, asialoglycoprotein receptor 1+ cells = 22%). The CYP expression levels and CYP activities in hiHeps were higher than those in human iPS cell-derived hepatocyte-like cells, but lower than those in short-term (4 hr) cultured primary human hepatocytes and primary human hepatocytes collected immediately after thawing. These results suggested that functional hiHeps could be efficiently generated by ATF5, PROX1, FOXA2, FOXA3, and HNF4A transduction. We believe that hiHeps generated by our method will be useful for the drug-discovery activities such as hepatotoxicity screening and drug metabolism tests.
- Published
- 2017
- Full Text
- View/download PDF
7. A mammalian mirtron miR-1224 promotes tube-formation of human primary endothelial cells by targeting anti-angiogenic factor epsin2.
- Author
-
Sakai E, Miura Y, Suzuki-Kouyama E, Oka K, Tachibana M, Kawabata K, Sakurai F, and Mizuguchi H
- Subjects
- 3' Untranslated Regions, Gene Expression Regulation drug effects, Gene Knockdown Techniques, Human Umbilical Vein Endothelial Cells, Humans, Receptors, Notch genetics, Receptors, Notch metabolism, Signal Transduction genetics, Up-Regulation, Vascular Endothelial Growth Factor A metabolism, Vascular Endothelial Growth Factor A pharmacology, Adaptor Proteins, Vesicular Transport genetics, MicroRNAs genetics, Neovascularization, Physiologic genetics
- Abstract
Angiogenesis, new vessel formation from pre-existing vessels, is a highly conserved event through vertebrates. However, the system for tuning angiogenesis by species-intrinsic factors is totally unknown. miR-1224 is a member of mammal-specific mirtrons, which were identified as non-canonical microRNAs. We found that the expression of miR-1224 was upregulated in capillary-like tube-forming human umbilical vein endothelial cells on Matrigel. Enforced expression of miR-1224 stimulated tube formation, whereas repression of endogenous miR-1224 inhibited formation. Enforced expression of miR-1224 enhanced VEGF signaling and repressed NOTCH signaling. The adaptor protein of clathrin-dependent endocytosis, epsin2, which has been shown to be a suppressor of angiogenesis, was a direct target of miR-1224. Knockdown of EPN2 stimulated tube formation, while overexpression of EPN2 repressed miR-1224-mediated stimulation. Our findings indicate that miR-1224 is a mammal specific modulator of angiogenesis.
- Published
- 2017
- Full Text
- View/download PDF
8. Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection.
- Author
-
Sakurai F, Mitani S, Yamamoto T, Takayama K, Tachibana M, Watashi K, Wakita T, Iijima S, Tanaka Y, and Mizuguchi H
- Subjects
- Cell Differentiation physiology, Cell Line, Hep G2 Cells, Hepatitis B genetics, Hepatitis B metabolism, Hepatitis B virus genetics, Hepatocytes metabolism, Host-Pathogen Interactions physiology, Humans, Induced Pluripotent Stem Cells metabolism, Organic Anion Transporters, Sodium-Dependent genetics, Organic Anion Transporters, Sodium-Dependent metabolism, RNA, Viral genetics, Symporters genetics, Symporters metabolism, Viral Proteins genetics, Viral Proteins metabolism, Hepatitis B pathology, Hepatitis B virology, Hepatocytes cytology, Hepatocytes virology, Induced Pluripotent Stem Cells cytology, Induced Pluripotent Stem Cells virology
- Abstract
In order to understand the life cycle of hepatitis B virus (HBV) and to develop efficient anti-HBV drugs, a useful in vitro cell culture system which allows HBV infection and recapitulates virus-host interactions is essential; however, pre-existing in vitro HBV infection models are often problematic. Here, we examined the potential of human induced-pluripotent stem (iPS) cell-derived hepatocyte-like cells (iPS-HLCs) as an in vitro HBV infection model. Expression levels of several genes involved in HBV infection, including the sodium taurocholate cotransporting polypeptide (NTCP) gene, were gradually elevated as the differentiation status of human iPS cells proceeded to iPS-HLCs. The mRNA levels of these genes were comparable between primary human hepatocytes (PHHs) and iPS-HLCs. Following inoculation with HBV, we found significant production of HBV proteins and viral RNAs in iPS-HLCs. The three major forms of the HBV genome were detected in iPS-HLCs by Southern blotting analysis. Anti-HBV agents entecavir and Myrcludex-B, which are a nucleoside analogue reverse transcriptase inhibitor and a synthetic pre-S1 peptide, respectively, significantly inhibited HBV infection in iPS-HLCs. These data demonstrate that iPS-HLCs can be used as a promising in vitro HBV infection model.
- Published
- 2017
- Full Text
- View/download PDF
9. Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells.
- Author
-
Imagawa K, Takayama K, Isoyama S, Tanikawa K, Shinkai M, Harada K, Tachibana M, Sakurai F, Noguchi E, Hirata K, Kage M, Kawabata K, Sumazaki R, and Mizuguchi H
- Subjects
- ATP Binding Cassette Transporter, Subfamily B, Member 11 genetics, Biological Transport, Biomarkers, Cell Differentiation, Cell Line, Cells, Cultured, Child, Cholestasis, Intrahepatic diagnosis, Cholestasis, Intrahepatic genetics, Cholestasis, Intrahepatic metabolism, Female, Gene Expression, Humans, Immunohistochemistry, Liver metabolism, Liver pathology, Mutation, Phenotype, RNA, Messenger genetics, Sequence Analysis, DNA, ATP Binding Cassette Transporter, Subfamily B, Member 11 metabolism, Bile Acids and Salts metabolism, Hepatocytes cytology, Hepatocytes metabolism, Induced Pluripotent Stem Cells cytology
- Abstract
Bile salt export pump (BSEP) plays an important role in hepatic secretion of bile acids and its deficiency results in severe cholestasis and liver failure. Mutation of the ABCB11 gene encoding BSEP induces BSEP deficiency and progressive familial intrahepatic cholestasis type 2 (PFIC2). Because liver transplantation remains standard treatment for PFIC2, the development of a novel therapeutic option is desired. However, a well reproducible model, which is essential for the new drug development for PFIC2, has not been established. Therefore, we attempted to establish a PFIC2 model by using iPSC technology. Human iPSCs were generated from patients with BSEP-deficiency (BD-iPSC), and were differentiated into hepatocyte-like cells (HLCs). In the BD-iPSC derived HLCs (BD-HLCs), BSEP was not expressed on the cell surface and the biliary excretion capacity was significantly impaired. We also identified a novel mutation in the 5'-untranslated region of the ABCB11 gene that led to aberrant RNA splicing in BD-HLCs. Furthermore, to evaluate the drug efficacy, BD-HLCs were treated with 4-phenylbutyrate (4PBA). The membrane BSEP expression level and the biliary excretion capacity in BD-HLCs were rescued by 4PBA treatment. In summary, we succeeded in establishing a PFIC2 model, which may be useful for its pathophysiological analysis and drug development., Competing Interests: The authors declare no competing financial interests.
- Published
- 2017
- Full Text
- View/download PDF
10. Tumor-specific delivery of biologics by a novel T-cell line HOZOT.
- Author
-
Onishi T, Tazawa H, Hashimoto Y, Takeuchi M, Otani T, Nakamura S, Sakurai F, Mizuguchi H, Kishimoto H, Umeda Y, Shirakawa Y, Urata Y, Kagawa S, and Fujiwara T
- Subjects
- Cell Line, Tumor, Humans, Neoplasms metabolism, Neoplasms pathology, Genetic Vectors, Membrane Cofactor Protein, Neoplasms therapy, Oncolytic Virotherapy methods, Oncolytic Viruses, T-Lymphocytes virology
- Abstract
"Cell-in-cell" denotes an invasive phenotype in which one cell actively internalizes in another. The novel human T-cell line HOZOT, established from human umbilical cord blood, was shown to penetrate a variety of human cancer cells but not normal cells. Oncolytic viruses are emerging as biological therapies for human cancers; however, efficient viral delivery is limited by a lack of tumor-specific homing and presence of pre-existing or therapy-induced neutralizing antibodies. Here, we report a new, intriguing approach using HOZOT cells to transmit biologics such as oncolytic viruses into human cancer cells by cell-in-cell invasion. HOZOT cells were successfully loaded via human CD46 antigen with an attenuated adenovirus containing the fiber protein of adenovirus serotype 35 (OBP-401/F35), in which the telomerase promoter regulates viral replication. OBP-401/F35-loaded HOZOT cells were efficiently internalized into human cancer cells and exhibited tumor-specific killing by release of viruses, even in the presence of anti-viral neutralizing antibodies. Moreover, intraperitoneal administration of HOZOT cells loaded with OBP-401/F35 significantly suppressed peritoneally disseminated tumor growth in mice. This unique cell-in-cell property provides a platform for selective delivery of biologics into human cancer cells, which has important implications for the treatment of human cancers., Competing Interests: Yasuo Urata is the president and CEO of Oncolys BioPharma, Inc., the manufacturer of viruses. Hiroshi Tazawa and Toshiyoshi Fujiwara are consultants for Oncolys BioPharma, Inc. The other authors have no real or potential conflicts of interest to declare.
- Published
- 2016
- Full Text
- View/download PDF
11. Dicer functions as an antiviral system against human adenoviruses via cleavage of adenovirus-encoded noncoding RNA.
- Author
-
Machitani M, Sakurai F, Wakabayashi K, Tomita K, Tachibana M, and Mizuguchi H
- Subjects
- Adenoviruses, Human metabolism, Animals, Base Sequence, DEAD-box RNA Helicases metabolism, Gene Expression Regulation, Genes, Reporter, HEK293 Cells, HeLa Cells, Hep G2 Cells, Humans, Luciferases genetics, Luciferases metabolism, MCF-7 Cells, Plasmids chemistry, Plasmids metabolism, RNA Interference, RNA, Untranslated metabolism, RNA, Viral metabolism, Ribonuclease III metabolism, Signal Transduction, Adenoviruses, Human genetics, DEAD-box RNA Helicases genetics, Host-Pathogen Interactions, RNA, Untranslated genetics, RNA, Viral genetics, Ribonuclease III genetics
- Abstract
In various organisms, including nematodes and plants, RNA interference (RNAi) is a defense system against virus infection; however, it is unclear whether RNAi functions as an antivirus system in mammalian cells. Rather, a number of DNA viruses, including herpesviruses, utilize post-transcriptional silencing systems for their survival. Here we show that Dicer efficiently suppresses the replication of adenovirus (Ad) via cleavage of Ad-encoding small RNAs (VA-RNAs), which efficiently promote Ad replication via the inhibition of eIF2α phosphorylation, to viral microRNAs (mivaRNAs). The Dicer knockdown significantly increases the copy numbers of VA-RNAs, leading to the efficient inhibition of eIF2α phosphorylation and the subsequent promotion of Ad replication. Conversely, overexpression of Dicer significantly inhibits Ad replication. Transfection with mivaRNA does not affect eIF2α phosphorylation or Ad replication. These results indicate that Dicer-mediated processing of VA-RNAs leads to loss of activity of VA-RNAs for enhancement of Ad replication and that Dicer functions as a defence system against Ad in mammalian cells.
- Published
- 2016
- Full Text
- View/download PDF
12. Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine.
- Author
-
Ozawa T, Takayama K, Okamoto R, Negoro R, Sakurai F, Tachibana M, Kawabata K, and Mizuguchi H
- Abstract
Enterocytes play an important role in drug absorption and metabolism. However, a widely used enterocyte model, Caco-2 cell, has difficulty in evaluating both drug absorption and metabolism because the expression levels of some drug absorption and metabolism-related genes in these cells differ largely from those of human enterocytes. Therefore, we decided to generate the enterocyte-like cells from human induced pluripotent stem (iPS) cells (hiPS-ELCs), which are applicable to drug absorption and metabolism studies. The efficiency of enterocyte differentiation from human iPS cells was significantly improved by using EGF, SB431542, and Wnt3A, and extending the differentiation period. The gene expression levels of cytochrome P450 3A4 (CYP3A4) and peptide transporter 1 in the hiPS-ELCs were higher than those in Caco-2 cells. In addition, CYP3A4 expression in the hiPS-ELCs was induced by treatment with 1, 25-dihydroxyvitamin D3 or rifampicin, which are known to induce CYP3A4 expression, indicating that the hiPS-ELCs have CYP3A4 induction potency. Moreover, the transendothelial electrical resistance (TEER) value of the hiPS-ELC monolayer was approximately 240 Ω*cm(2), suggesting that the hiPS-ELC monolayer could form a barrier. In conclusion, we succeeded in establishing an enterocyte model from human iPS cells which have potential to be applied for drug absorption and metabolism studies.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.